Recombinant multi-species Endothelin 1/EDN1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Endothelin 1/EDN1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a preproprotein that is proteolytically processed to generate a secreted peptide that belongs to the endothelin/sarafotoxin family. This peptide is a potent vasoconstrictor and its cognate receptors are therapeutic targets in the treatment of pulmonary arterial hypertension. Aberrant expression of this gene may promote tumorigenesis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
The Alternative Names of target: ARCND3,EDN1,ET-1,ET1,Edn1,Endothelin 1,Endothelin-1,Et1,HDLCQ7,PPET1,Preproendothelin-1 (PPET1),QME,preproET
Go
to Endothelin 1/EDN1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T25076-Ag-1/ GM-Tg-hg-T25076-Ag-2 | Human Endothelin 1/EDN1 protein | Human |
| GM-Tg-rg-T25076-Ag-1/ GM-Tg-rg-T25076-Ag-2 | Rat Endothelin 1/EDN1 protein | Rat |
| GM-Tg-mg-T25076-Ag-1/ GM-Tg-mg-T25076-Ag-2 | Mouse Endothelin 1/EDN1 protein | Mouse |
| GM-Tg-cynog-T25076-Ag-1/ GM-Tg-cynog-T25076-Ag-2 | Cynomolgus/Rhesus macaque Endothelin 1/EDN1 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T25076-Ag-1/ GM-Tg-felg-T25076-Ag-2 | Feline Endothelin 1/EDN1 protein | Feline |
| GM-Tg-cang-T25076-Ag-1/ GM-Tg-cang-T25076-Ag-2 | Canine Endothelin 1/EDN1 protein | Canine |
| GM-Tg-bovg-T25076-Ag-1/ GM-Tg-bovg-T25076-Ag-2 | Bovine Endothelin 1/EDN1 protein | Bovine |
| GM-Tg-equg-T25076-Ag-1/ GM-Tg-equg-T25076-Ag-2 | Equine Endothelin 1/EDN1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T25076-Ag-1/ GM-Tg-hg-T25076-Ag-2;
GM-Tg-rg-T25076-Ag-1/ GM-Tg-rg-T25076-Ag-2;
GM-Tg-mg-T25076-Ag-1/ GM-Tg-mg-T25076-Ag-2; GM-Tg-cynog-T25076-Ag-1/ GM-Tg-cynog-T25076-Ag-2; GM-Tg-felg-T25076-Ag-1/ GM-Tg-felg-T25076-Ag-2; GM-Tg-cang-T25076-Ag-1/ GM-Tg-cang-T25076-Ag-2; GM-Tg-bovg-T25076-Ag-1/ GM-Tg-bovg-T25076-Ag-2; GM-Tg-equg-T25076-Ag-1/ GM-Tg-equg-T25076-Ag-2 |
| Products Name | Endothelin 1/EDN1 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | Endothelin 1/EDN1 |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Endothelin 1/EDN1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.